Prof. Dr. Ibrahim H. Eissa is an Associate Professor of Medicinal Chemistry and the Manager of the Quality Assurance Unit at the Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt. He obtained his B.Sc. in 2003, his M.Sc. in Medicinal Chemistry in 2009, and his Ph.D. degree in 2012, all from the Faculty of Pharmacy (Boys), Al-Azhar University. Since 2017, he has been an Associate Professor at Al-Azhar University, and was made a manager of QAU in 2018. His scientific activity is focused on the design, molecular modeling studies and synthesis of new bioactive compounds with potential anticancer activity against EGFR, VEGFR-2, Topoisomerases, tubulins, carbonic anhydrases, and thymidylate synthase. Recently, he has been interested in the design and discovery of SARS-CoV-2 inhibitors.